Skip to main content
. Author manuscript; available in PMC: 2020 Dec 15.
Published in final edited form as: Cancer Res. 2020 Apr 3;80(12):2441–2450. doi: 10.1158/0008-5472.CAN-19-1696

Figure 4. The innate immune genes and LTRs show responder-specific upregulation in pediatric patients.

Figure 4.

A, Relative expression of immune response– and leukocyte activation–related gene in pediatric AML and ALL patients (n = 14). B, Relative expression of two LTRs in pediatric AML and ALL patients (n = 14). Black lines represent median values. The highest values obtained at any of the multiple time points are shown as the posttreatment value. P-values were calculated using the two-tailed Wilcoxon Signed-Rank Test for comparisons between the two groups. (*); P < 0.05, (**); P < 0.01, (n.s.); not significant.